Core Insights - ONWARD Medical N.V. has appointed Ali Kiboro as Chief Financial Officer effective January 2026, bringing over 25 years of financial leadership experience in the medical technology sector [1][2][3] Company Overview - ONWARD Medical is a neurotechnology company focused on spinal cord stimulation therapies aimed at restoring movement, function, and independence for individuals with spinal cord injuries and other movement disabilities [4][5] - The company has developed proprietary ARC Therapy and has received 10 Breakthrough Device Designations from the FDA, with its ARC EX System cleared for commercial sale in the US and Europe [4] - ONWARD is also working on an investigational implantable system called ARC-IM, which addresses unmet needs such as blood pressure instability after spinal cord injury and can integrate with brain-computer interfaces and artificial intelligence [4] Leadership and Strategy - CEO Dave Marver expressed confidence in Ali Kiboro's ability to drive growth and scale within the life sciences sector, highlighting the importance of Kiboro's experience at this critical stage for ONWARD [3] - Ali Kiboro holds an MBA in Finance from The Wharton School and a Bachelor of Science in Finance, summa cum laude, from Duquesne University, indicating a strong educational background in finance [3]